Abstract
BackgroundChronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) often coexist and are associated with a high morbidity and reduced quality of life (QoL). Although these diseases share similarities in symptoms and clinical course, and exacerbations of both diseases often overlap, care pathways for both conditions are usually not integrated. This results in frequent outpatient consultations and suboptimal treatment during exacerbations, leading to frequent hospital admissions. Therefore, we propose an integrated care pathway for both diseases, using telemonitoring to detect deterioration at an early stage and a single case manager for both diseases.ObjectiveThis study aims to investigate whether an integrated care pathway using telemonitoring in patients with combined CHF and COPD results in a higher general health-related QoL (HRQoL) as compared with the traditional care pathways. Secondary end points include disease-specific HRQoL, level of self-management, patient satisfaction, compliance to the program, and cost-effectiveness.MethodsThis is a monocenter, prospective study using a quasi-experimental interrupted time series design. Thirty patients with combined CHF and COPD are included. The study period of 2.5 years per patient is divided into a preintervention phase (6 months) and a postintervention phase (2 years) in which end points are assessed. The intervention consists of an on-demand treatment strategy based on monitoring symptoms related to CHF/COPD and vital parameters (weight, blood pressure, heart rate, oxygen saturation, temperature), which are uploaded on a digital platform. The monitoring frequency and the limit values of the measurements to detect abnormalities are determined individually. Monitoring is performed by a case manager, who has the opportunity for a daily multidisciplinary meeting with both the cardiologist and the pulmonologist. Routine appointments at the outpatient clinic are cancelled and replaced by telemonitoring-guided treatment.ResultsFollowing ethical approval of the study protocol, the first patient was included in May 2018. Inclusion is expected to be complete in May 2021.ConclusionsThis study is the first to evaluate the effects of a novel integrated care pathway using telemonitoring for patients with combined CHF and COPD. Unique to this study is the concept of remote on-demand disease management by a single case manager for both diseases, combined with multidisciplinary meetings. Moreover, modern telemonitoring technology is used instead of, rather than as an addition to, regular care.Trial RegistrationNetherlands Trial Register NL6741; https://www.trialregister.nl/trial/6741International Registered Report Identifier (IRRID)DERR1-10.2196/20571
Highlights
BackgroundChronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) often coexist because they share similar risk factors, of which smoking and low-grade systemic inflammation are the most significant [1]
This study aims to investigate whether an integrated care pathway using telemonitoring in patients with combined CHF and COPD results in a higher general health-related quality of life (QoL) (HRQoL) as compared with the traditional care pathways
This study is the first to evaluate the effects of a novel integrated care pathway using telemonitoring for patients with combined CHF and COPD
Summary
BackgroundChronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) often coexist because they share similar risk factors, of which smoking and low-grade systemic inflammation are the most significant [1]. The prevalence of CHF in patients with COPD is approximately 20%, while the reported prevalence of COPD in patients with CHF ranges from 10% up to 50%, depending on the population studied and diagnostic criteria used to define COPD and CHF [1,2] Both diseases share a chronic, progressive character and are associated with a poor quality of life (QoL) [3,4]. Chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) often coexist and are associated with a high morbidity and reduced quality of life (QoL) These diseases share similarities in symptoms and clinical course, and exacerbations of both diseases often overlap, care pathways for both conditions are usually not integrated. We propose an integrated care pathway for both diseases, using telemonitoring to detect deterioration at an early stage and a single case manager for both diseases
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
